Lumito AB:s TO10 options trading to commence August 28, 2026
Lumito AB's TO10 options will begin trading on August 28, 2026, with the last trading day set for January 14, 2027. The options were issued in connection with the company's unit issue.
Trading in Lumito AB's subscription options series TO10 is scheduled to commence on August 28, 2026. The options were issued as part of the company's recent unit offering.
The final day for trading these options will be January 14, 2027. These TO10 options provide holders with the right to subscribe for new shares in Lumito AB at a predetermined price within a specified timeframe.
Lumito AB is a company focused on developing and commercializing new technology for medical imaging, aiming to improve diagnostics, particularly for conditions like cancer. Their technology seeks to enhance image quality and diagnostic accuracy.
The listing information for the instrument, identified by ISIN code SE0029605435, indicates it is traded on Nasdaq First North Growth Market. The financing through this option series supports Lumito's ongoing research and development efforts.